METHYL (2S,4S)-4-[4-(TERT-BUTYL)PHENOXY]-2-PYRROLIDINECARBOXYLATE
![]() |
- $205 - $412.65
- Product name: METHYL (2S,4S)-4-[4-(TERT-BUTYL)PHENOXY]-2-PYRROLIDINECARBOXYLATE
- CAS: 774221-39-5
- MF: C16H23NO3
- MW: 277.36
- EINECS:
- MDL Number:MFCD08688201
- Synonyms:METHYL (2S,4S)-4-[4-(TERT-BUTYL)PHENOXY]-2-PYRROLIDINECARBOXYLATE;methyl (2S,4S)-4-(4-tert-butylphenoxy)pyrrolidine-2-carboxylate;L-Proline, 4-[4-(1,1-dimethylethyl)phenoxy]-, methyl ester, (4S)-
3 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500mg
- ManufacturerAK Scientific
- Product number9585AE
- Product descriptionMethyl(2S,4S)-4-[4-(tert-butyl)phenoxy]-2-pyrrolidinecarboxylate
- Packaging500mg
- Price$326
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCCH0005201
- Product descriptionMETHYL-(2S,4S)-4-[4-(TERT-BUTYL)PHENOXY]-2-PYRROLIDINECARBOXYLATE 95.00%
- Packaging500MG
- Price$412.65
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number023672
- Product descriptionMethyl (2S,4S)-4-[4-(tert-butyl)phenoxy]-2-pyrrolidinecarboxylate
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 9585AE | Methyl(2S,4S)-4-[4-(tert-butyl)phenoxy]-2-pyrrolidinecarboxylate | 500mg | $326 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CCH0005201 | METHYL-(2S,4S)-4-[4-(TERT-BUTYL)PHENOXY]-2-PYRROLIDINECARBOXYLATE 95.00% | 500MG | $412.65 | 2021-12-16 | Buy |
Matrix Scientific | 023672 | Methyl (2S,4S)-4-[4-(tert-butyl)phenoxy]-2-pyrrolidinecarboxylate | 500mg | $205 | 2021-12-16 | Buy |
Properties
Boiling point :375.3±42.0 °C(Predicted)
Density :1.072±0.06 g/cm3(Predicted)
pka :7.10±0.10(Predicted)
Density :1.072±0.06 g/cm3(Predicted)
pka :7.10±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|